Damon Inc美股招股说明书(2025-07-18版)

Filed Pursuant to Rule 424(b)(3)Registration No. 333-285981Registration No. 333-285872Registration No. 333-282359Registration No. 333-284324 Prospectus Supplement No. 10(to Prospectus dated March 20, 2025)Prospectus Supplement No. 20(to Prospectus dated November 12, 2024)Prospectus Supplement No. 13(to Prospectus dated February 6, 2025) DAMON INC. Offering of 126,900,000 Units, Each Unit Consisting of One Common Share and One Series A Warrant, and126,900,000 Common Shares* Underlying Series A Warrants and 6,345,000 Common Shares* UnderlyingUnderwriter’s WarrantsResale of Up to 1,015,383 Common Shares by the Selling SecurityholdersResale of Up to 18,514,579 Common Shares by the Selling Securityholders This prospectus supplement is being filed to update and supplement information contained in (i) the prospectus dated March20, 2025 related to the offering of 126,900,000 units, each unit consisting of one common share, no par value (“common shares”) andone Series A Warrant (“Series A Warrant”), of Damon Inc., a British Columbia corporation (“Damon”), and 126,900,000 commonshares (*or a greater amount pursuant to an alternate cashless exercise option in accordance with the terms of the warrants) underlyingthe Series A Warrants and 6,345,000 common shares (*or a greater amount pursuant to an alternate cashless exercise option inaccordance with the terms of the warrants) underlying the Underwriter’s Warrants, (ii) the prospectus dated November 12, 2024 relatedto the resale of up to 1,015,383 common shares of Damon, and (iii) the prospectus dated February 6, 2025 related to the to the resale ofup to 18,514,579 common shares of Damon (together, the “Prospectuses”), with the information contained in our Current Report onForm 8-K, filed with the Securities and Exchange Commission (the “SEC”) on July 17, 2025 (the “Current Report”). Accordingly, wehave attached the Current Report to this prospectus supplement. This prospectus supplement updates and supplements the information in the Prospectuses and is not complete without, andmay not be delivered or utilized except in combination with, the Prospectuses, including any amendments or supplements thereto. Thisprospectus supplement should be read in conjunction with the Prospectuses and if there is any inconsistency between the informationin the Prospectuses and this prospectus supplement, you should rely on the information in this prospectus supplement. Our common shares are traded on the OTCID Basic Market currently under the symbol “DMNID,” which will revert to“DMNIF” 20 business days after July 3, 2025, the effective date of the reverse stock split disclosed in the Current Report. On July 16,2025, the closing price of our common shares was $ 0.092 per share. Investing in our securities involves risks. See the sections titled “Risk Factors” of the Prospectuses and in anyapplicable prospectus supplement. Neither the Securities and Exchange Commission nor any other regulatory body have approved or disapproved thesesecurities, or passed upon the accuracy or adequacy of this prospectus supplement. Any representation to the contrary is a criminaloffense. The date of this prospectus supplement is July 17, 2025. USSECW, D. C. 20549 FORM 8-K CURRENT REPORTPursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 16, 2025 DAMON INC.(Exact name of registrant as specified in its charter) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrantunder any of the following provisions (see General Instruction A.2. below): Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Name of Each Exchange on WhichRegistered The Nasdaq Stock Market LLC* *As previously reported, The Nasdaq Stock Market LLC has determined to delist the Company’s common shares, and hassuspended its trading as of May 20, 2025. The Company’s common shares are currently quoted on the OTCID Basic Market,operated by OTC Markets Group, Inc., under the symbol “DMNIF.” Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933(§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company☒ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period forcomplying with any new or revised financial accounting standards provided pursuant to